Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 10, 2016 - Issue
Submit an article Journal homepage
60
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study

Atsushi Tsuruta1 Department of Digestive Surgery, Kawasaki Medical School HospitalCorrespondence[email protected]
,
Kazuki Yamashita2 Department of Surgery
,
Hiroaki Tanioka3 Department of Medical Oncology, Okayama Rosai Hospital, Okayama
,
Akihito Tsuji4 Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe;5 Department of Clinical Oncology, Faculty of Medicine, Kagawa University Hospital, Kagawa
,
Michio Inukai6 Department of Medicine, Okayama Saiseikai General Hospital, Okayama
,
Toshiki Yamakawa7 Department of Surgery, Kagawa Prefectural Central Hospital, Takamatsu
,
Tomoki Yamatsuji8 Department of General Surgery, Kawasaki Medical School, Okayama
,
Masanori Yoshimitsu9 Department of Surgery, Hiroshima City Asa Hospital, Hiroshima
,
Kazuhiro Toyota10 Department of Surgery, National Hospital Organization Higashihirosima Medical Center, Higashihiroshima
,
Taketoshi Yamano11 Department of Surgery, Kurashiki Medical Center
,
Takeshi Nagasaka12 Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama
&
Masazumi Okajima13 Department of Surgery, Hiroshima City Hospital, Hiroshima, Japan
 show all
Pages 3827-3835 | Published online: 23 Nov 2016

References

  • FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer2010127122893291721351269
  • SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin201565152925559415
  • PennaCNordlingerBColorectal metastasis (liver and lung)Surg Clin North Am20028251075109012507210
  • National Comprehensive Cancer NetworkClinical Practice Guidelines in Oncology, Colon Cancer version 22016
  • WatanabeTItabashiMShimadaYJapanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2014 for the treatment of colorectal cancerInt J Clin Oncol201520220723925782566
  • AndreTBoniCMounedji-BoudiafLOxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancerN Engl J Med2004350232343235115175436
  • AndreTBoniCNavarroMImproved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC TrialJ Clin Oncol200927193109311619451431
  • KueblerJPWieandHSO’ConnellMJOxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07J Clin Oncol200725162198220417470851
  • HallerDGTaberneroJMarounJCapecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancerJ Clin Oncol201129111465147121383294
  • O’ConnellMJLaurieJAKahnMProspectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancerJ Clin Oncol19981612953009440756
  • HallerDGCatalanoPJMacdonaldJSPhase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089J Clin Oncol200523348671867816314627
  • ChauINormanARCunninghamDA randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancerAnn Oncol200516454955715695501
  • de GramontAFigerASeymourMLeucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancerJ Clin Oncol200018162938294710944126
  • HausheerFHSchilskyRLBainSDiagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathySemin Oncol2006331154916473643
  • BokuNOhtsuAHyodoIPhase II study of oxaliplatin in japanese patients with metastatic colorectal cancer refractory to fluoropyrimidinesJpn J Clin Oncol200737644044517656482
  • GoldbergRMSargentDJMortonRFA randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancerJ Clin Oncol2004221233014665611
  • LoprinziCLQinRDakhilSRPhase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance)J Clin Oncol20143210997100524297951
  • OkiEEmiYKojimaHPreventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III studyInt J Clin Oncol201520476777525627820

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.